drugset / Trial / NCT01086423
Immunogenicity and Safety Study of GSK Biologicals' Infanrix-IPV+Hib™ Vaccine
RandomizedParallel-groupOpen-labelPrevention
Summary
The purpose of the study is to evaluate the immunogenicity and reactogenicity of Infanrix-IPV/Hib™ vaccine when administered to healthy Chinese infants at 2, 3 and 4 or 3, 4 and 5 months of age.
Timeline
- Start
- 2010-03-01
- Primary completion
- 2010-11-19
- Completion
- 2010-11-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Infanrix Hib™ | Vaccine | — | Intramuscular |
| Subject | Infanrix-IPV+Hib™ | Vaccine | — | Intramuscular |
| Comparator | Poliorix™ | Vaccine | — | Intramuscular |